Results for "consumer data right"
221-230 of 556 results for 'consumer data right'
Privacy disclosure incident leads to largest ever award of compensation for non-economic loss.
The determination issued by the OAIC for breaches of the Privacy Act by the Department of Home Affairs confirms that compensation can be ordered to be paid for non-economic losses related to data breaches. ...
Guide to addressing ESG impacts in generative AI deployment
This guide outlines key ESG risks and impacts companies deploying AI should consider, the questions they should be asking, and what to do in response. ...
Takeaways from recent guidance on cyber incident disclosure obligations for listed companies
In this Insight, we examine the guidance note and related developments and offer our view as to when disclosure (for the purposes of the ASX listing rule requirements) of cyber incidents should generally only occur. ...
Preparing for voluntary standards and mandatory legislation: a deep dive into Australia's evolving AI regulatory landscape
Over the past few weeks, the Australian Government has published a series of standards, proposals and policies which foreshadow the principles likely to be adopted in mandatory AI legislation once introduced. ...
AI Governance Toolkit for General Counsel and Boards
We believe companies need to start applying guardrails to AI development, use and deployment, but we understand that it can be hard to know where and how to start. That's why we've developed an AI Governance Toolkit for General Counsel and Boards, to help companies manage their AI risk. ...
Towards a waterfall model: insights from eSafety’s Consultation and the Age Assurance Technology Trial
On 10 December 2025, the Government's social media minimum age restrictions will take effect. Against this backdrop, on 1 September, the Department of Infrastructure, Transport, Regional Developm ...
Repurposing existing medicines – industry to have its say in reshaping Australia's regulatory future
The Therapeutics Goods Administration (the TGA) is consulting with the public and industry to potentially reform regulatory and reimbursement frameworks, to incentivise the repurposing of existing medicines. Off-label use (where a medicine is used for a disease or medical condition for which it does ...
Applying for a patent term extension in Australia? The formulation for success has changed
On 1 December 2025, the Federal Court of Australia exercising its appellate jurisdiction (the Full Court) handed down a bombshell decision: while patents for new active pharmaceutical ingred ...
Design to delivery: a guide to outsourcing
Whether your organisation is currently planning a BPO or considering it as a future option, this guide outlines everything you need to know through the various stages of your next BPO. ...
Ever-expanding jurisdiction: Clearview AI's appeal and extra-territorial application of the Privacy Act
A landmark ruling in Australia confirms that Clearview AI breached the Privacy Act despite lacking a physical presence or supplying products or services in the country, emphasising the extraterritorial reach of privacy laws and the consequences for companies. ...